References

Bray F, Loos AH, McCarron P et al. (2005). Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14:677-86.

Chaturvedi AK, Engels EA, Pfieffer RM et al. (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the Unites States. J Clin Oncol 29:4294-301.

Cubie HA, Cuschieri K (2013). Understanding HPV tests and their appropriate applications.  Cytopathology 24:289-308.

de Sanjose S, Quint WGV, Alemany L et al. (2010). Human papillomvirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional survey. Lancet Oncol 11:1048-56.

EUCAN [URL to come]

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374-403.

Frazer IH (2004). Prevention of cervical cancer through papillomavirus vaccination. Nature Rev Immunol 4:46-55.

Gadducci A, Barsotti C, Cosio S, Domenici L, Genazzani AR (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinonogenesis: a review of the literature.  Gynecol Endocrinol 27:597-604.

Gillison ML, Koch WM, Capone RB et al. (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-20.

Hogewoning CJA, Bleeker MCG, van den Brule AJC et al. (2003). Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer107:811-6.

International Collaboration of Epidemiological Studies of Cervical Cancer (2006). Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 120:885-91.

Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011). Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927-35.

Piyathlake CJ, Henao OL, Macaluso M et al. (2004). Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788-93.

Walboomers JM, Jacobs MV, Manos MM et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-9.

World Health Organisation (2012). International Agency for Research on Cancer. GLOBOSCAN 2012 : Estimated cancer  incidence, mortality and prevalence worldwide in 2012. Available online: www:http://globocan.iarc.fr/Pages/fact_sheet_population.aspx (Accessed 14 January 2015).

zur Hausen H (2002).  Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer 2:342-50.

X